(Pfizer) – Outside of her work at Pfizer and as a geriatric psychiatrist, Dr. Faison tirelessly collaborates with the Alzheimer’s Association and American Heart Association. She spends countless hours in the community participating in health fairs and seminars to educate the community-at-large about Alzheimer’s disease and cardiovascular diseases.
(Bayer Corporation) Dr. Nadal is an advocate for health professionals and patients. A champion for clinical pharmacists, Juan has been instrumental in Bayer’s PharmD Fellowship program with Rutgers University, which enables new PharmD’s to have a better inside view of the biopharmaceutical industry.
(Sanofi US) – Jackie has emerged as a champion of the biopharmaceutical industry through working with Sanofi US’s grassroots program, VOICES, and serving as a “Civic Champion” who educates and recruits fellow employees to be active politically.
Brendan and the Novartis Emergency Management team was called into action to lead the company’s U.S. COVID-19 response team. His tasks included procuring and delivering 125,000 face coverings, 16,000 thermometers and 5,000 field force kits (masks, gloves, sanitizer, wipes). He also monitored and coordinated differing regulatory compliance requirements across 50 states while instituting an active
(Celgene) – Michael has advocated on behalf of Celgene’s public policy priorities at both the federal and state levels as a Celgene Ambassador. The Celgene Ambassadors program is a group of more than 50 employees who help colleagues understand why what happens in Washington, D.C. and state capitols impacts Celgene and the patients it serves.
In her role at J&J, Dr. Nicholson develops an overarching women’s health strategy with a focus on maternal health. She has carried this torch by driving investment in policies and solutions to address the U.S. maternal mortality crisis, partnering with national maternal health leaders to identify and take action toward solutions. She has hosted maternal
Jen has volunteered her time to help educate federal legislators on Biogen’s public policy goals. She has traveled to DC several times to meet with Biogen’s Government Affairs team and members of Congress. She has a unique talent for explaining the complexities of drug pricing and value-based contracting so that members of Congress and their
Anthony is one of Novartis’ champions who has been a great advocate for Novartis and patients, meeting with key members of state legislatures across the U.S. He has gone above and beyond to educate policymakers about the importance of R&D and innovative therapies while highlighting the challenges and expenses of bringing new medicines to the
Dr. Osei-Wusu provides critical input into the strategy, development and implementation of studies in the company’s cardiovascular program. She has represented Novartis at both the American College of Cardiology and the American Heart Association Scientific Congresses. And is also an active member of Women of Color in Pharma. Over the last year, she has partnered
Dr. Osinusi advocates for policies that encourage therapies to combat emerging viruses. This includes educating policymakers and administration officials on how intellectual property protections enabled the R&D that was so crucial to Gilead’s response to the COVID-19 pandemic. It also includes her work to explain how policies that undermine IP protections, like the TRIPS waiver,